Updated 22:20 GMT, 30 Oct 2026 SPX 7,580.07 -1.82% NDX 28,384.85 -3.46% VIX 19.42 +12.91% GOLD 3,884.90 -3.63% CL 102.95 +0.93% BTC 76,561.30 -1.56%
NAS100 28,385 −3.46% S&P 7,580 −1.82% GOLD $3,885 −3.63% BTC $76,561 −1.56% VIX 19.42 +12.91% prices · as of 22:20 UTC · 30 Oct
Vol. II · No. 304Saturday, 31 October 2026
TTitan Protect
Case Studies · Earnings Echo

AstraZeneca Reported: Clears One of Our Screens, With a Caveat on the Stricter Standard.

Filed Friday 30 October 2026 · 23:30 UTC · Entry no. 133178 · scored against the close · never edited

AstraZeneca Reported: Clears One of Our Screens, With a Caveat on the Stricter Standard.
Earnings Review · 30 October 2026
The print
Revenue $15.38B. EPS $1.00 vs $1.15 expected.
What changed versus going in
Earnings came in at $1.00 a share against $1.15 expected, a miss of 13% (-$0.15 a share).
Did the flow confirm the move?
Underlying money flow reads as distribution (21-day Chaikin Money Flow -0.08, five-day price change +0.6%, as of 2026-10-28, desk flow model).
Give the business its due
The business itself is genuinely strong: revenue growing about 12%, net margins near 17%, a moderate competitive moat, backed by a 24% return on equity.
Levels that matter
At $169.51 the shares sit 20% below the 52-week high of $212.71 and 24% above the low of $136.16 (44% of the way up the range). The 50-day average is $163.08, below the price. The 200-day average is $180.05, above the price.
The valuation lens
The shares trade close to our fair-value estimate (-5% margin of safety): fairly priced, little cushion for a miss. Fair value lands near $162 against a $169.51 share price, a margin of safety of about -5%. The trailing multiple sits around 27 times earnings, which only makes sense if the growth holds.
The ethical lens, our differentiator
Clears the faith-based (AAOIFI) screen and sits borderline on our broader anchor screen. Compliant with a caveat, weigh the divergence for your own conviction.
The verdict for a values-conscious investor
It clears the screen; size it to your own risk and conviction. One quarter, strong or soft, does not decide whether a holding is suitable.

This is analysis, not financial advice. Always manage your risk.

How This Entry Scores

Every level named in a session brief is scored against the next scheduled close. Nothing is edited after filing: if a level breaks, the record shows it as filed, not as corrected. The desk's full scored history sits on the track record page.

Continue Reading View all Case Studies →
Membership

The ledger is public. The desk behind it is not.

Membership opens every room and every entry the day it is filed, with the same dated honesty the record is built on.

Join the desk

This is analysis, not financial advice. Always manage your risk.

Get our weekly market brief free.